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Inhibition of tobramycin reabsorption in nephron segments by meta-
bolic alkalosis. Chronic metabolic acidosis appears to potentiate amino-
glycoside induced nephrotoxicity and renal cortical accumulation while
some, but not all, studies show that bicarbonate loading reduces
nephrotoxicity. The purpose of the present study was to determine if
reabsorption of tobramycin in proximal and distal nephron segments in
vivo is altered by systemic pH. To test this possibility on the single
nephron level, 24 nI samples of PH] tobrainycin were micro-injected
into proximal and distal nephron segments, and its recovery was
compared to that of [14C1 inulin in rats undergoing osmotic diuresis with
NaHCO3 or Na2SO4 containing HCI. Results were obtained in 66
tubules in 20 rats. Although plasma and urine pH were altered as
anticipated in bicarbonate-infused and acid-infused animals, urine and
late proximal tubule flow rates were similar. When animals were acid
infused, 24.8 1.90% of [3H] tobramycin injected into proximal
nephrons was reabsorbed compared to 7.5 1.56% (P < 0.001) when
the animals were bicarbonate-infused. When PHI tobramycin was
injected into distal tubules, 5.9 0.75%was reabsorbed in acid-infused
rats while virtually none of the injected tobramycin, 0.43 1.59%, was
reabsorbed by the distal nephron of bicarbonate-loaded animals. Our
results provide evidence that tobramycin reabsorption by both proximal
and distal nephron segments is substantially reduced by bicarbonate-
infusion.
Tobramycin is a single factor, aminoglycoside, bactericidal
agent used in the treatment of gram-negative bacteria. The
ammoglycoside antibiotics are rapidly excreted unchanged in
the urine following intravenous or intramuscular administration
in subjects with normal renal function [1]. Although less toxic
than streptomycin, the first aminoglycoside antibiotic, it still
has considerable nephro- and ototoxicity. Tobramycin has five
ionizable amino groups. Its structure is similar to that of
gentamicin Cia. Tobramycin would be expected to have an
average pk of about 8.4, [reviewed in 2] which renders it a
polycation at physiological pH. There is evidence [3—5] of
charge interaction between the amino groups of the aminogly-
coside antibiotics and acidic phospholipids of the brush border
membrane of the proximal tubule. Gentamicin binding is elim-
inated by treatment of brush border membranes with phospho-
lipases A and C, but is not affected by treatment with proteo-
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lytic enzymes [31. Consistent with these observations are the
results of recent studies which suggest that aminoglycosides
bind to phosphatidyl 4-5 bisphosphate (PIP2) [reviewed in 6]
and that gentamicin inhibits hormone specific activation of the
phosphatidyl inositol cascade [61. Binding is specific, saturable
and competitive for structurally related aminoglycosides [3—5].
Boundgentamicin is subsequently internalized in proximal cells
[7, 8]. Consistent with these findings are the results of a
microinjection study by Pastoriza-Munoz, Bowman and Kaloy-
anides [9] which showed that gentasnicin was reabsorbed by
proximal nephron segments in normal rats.
Since nephrotoxicity induced by gentamicin appears to be
related to cortical accumulation [10, 11], studies have been
undertaken to determine if changes in systemic pH would alter
renal accumulation and consequently the degree of renal insuf-
ficiency [2, 12—14]. For example, when [H] of plasma in-
creases (that is, pH falls) this would increase the net charge on
an aminoglycoside, which would be expected to enhance bind-
ing to brush border membranes and subsequent uptake by
proximal cells. The results of these studies are not in agree-
ment, however, regarding the affect of metabolic alkalosis or
acidosis on cortical uptake and nephrotoxicity induced by
gentamicin [2, 12—14]. For example, metabolic alkalosis in-
duced by NaHCO3 administration in the drinking water was not
found to reduce renal cortical gentamicin accumulation and/or
reduce histological damage in the study by Effiot et al [2]. In
fact NaHCO3 treatment was associated with rather marked
renal calcification. On the other hand, Agnedjian et al [14]
recently showed that NaHCO3 administration reduced cortical
gentamicin accumulation, ameliorated renal insufficiency and
abolished histological damage induced by gentamicin. Simi-
larly, NH4C1 administration has been shown to worsen genta-
micin-induced nephrotoxicity by Elliot et al [21 but not by Chiu
et al [13].
The purpose of the present study is to determine if reabsorp-
tion of tobramycin, a third generation aminoglycoside, by
proximal and distal nephron segments in vivo is altered by
changes in systemic pH. To test this possibility on the single
nephron level, 24 nI samples of [3H] tobramycin were micro-
injected into proximal and distal nephron segments and their
recovery was compared to that of ['4C] inulin in rats undergoing
osmotic diuresis with NaHCO3 or Na2SO4 containing HCI.
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Methods
Preparation of animals and micropuncture experiments
Experiments were performed on 26 male Sprague-Dawley
rats ranging in weight from 280 to 380 g (Charles-River Labo-
ratories, Montreal, Canada). They were anesthetized with an
intraperitoneal injection of mactin (Byk-Gulden, Konstanz,
FRG), 100 mg/kg body wt. Polyethylene catheters were inserted
into the left carotid artery for continuous blood pressure
monitoring and blood sampling and into the left and right jugular
veins for infusions. To create high urine flow rates with elevated
urine pH, which allowed rapid serial collections of urine, 13 rats
were infused with 0.3 M NaHCO3. To produce comparable
urine flow rates with reduced urine pH, 13 rats were infused
with 0.15 M Na2SO4 containing 0.12 M HC1. This is a modifica-
tion of a protocol used in a previous study [15]. These solutions
were infused at the rate of 2.0 mlIlOO g body weight per hour.
Infusion of NaHCO3 or Na2SO4 and acid was initiated as soon
as the jugular vein was catheterized. The rat was prepared for
micropuncture of cortical nephron segments as previously
described [16]. Following a 30-minute equilibrium period, timed
collections (15 mm) of urine were made for the purpose of
assessing urine pH and flow rate. In seven rats in each group,
urine collections were made before and after the completion of
the microinjection experiment. Blood was collected from each
animal for the measurement of pH and total [C02]. The exper-
iment was terminated if the arterial blood pressure fell below 90
mm Hg, proximal transit time of lissamine green dye was
greater than 13 seconds or there was retention of dye in distal
tubules.
Approximately ninety minutes after initiation of bicarbonate
or acid infusion, early proximal and early distal nephron seg-
ments were identified following the systemic injection of 25 pA
of a 10% lissamine green dye solution [16]. The tubules were
injected with a 100 m NaCI solution containing [14C] inulin, 40
CiIml (Dupont-New England Nuclear, Montreal) and [3H]
tobramycin, 80 jsCilml (custom synthesis, sp, activity 13.8
[Batch 11-14.7 [Batch 2] Cilmmol, Amersham International,
Illinois, USA). All of the experiments were performed using
two batches of isotope within four to five weeks of shipment.
The purity of the isotope was stated to be: Batch I = 96.0%,
Batch 2 = 96.4%, by HPLC on the date of shipment. Purity was
confirmed in our laboratory using thin layer chromatography on
silica in methanol: ammonia solution (density 0.88 g/nil) : water
(60:20:20). The estimated rate of decomposition was 2%/month.
Experiments alternated between bicarbonate infusion and acid
infusion throughout the duration of the study.
Proximal and distal nephrons were usually studied in each
animal. The solution was lightly colored with 0.1% Hercules
Green dye No.2 FD and C (Kohnstamm Inc., Montreal, Cana-
da). To ensure that the 3H tobramycin solution attained the
same pH as the endogenous tubular fluid, it would be ideal to
adjust the injectate pH to match that of the nephron segment
under study. However, because bicarbonate containing solu-
tions bleached the dye required for visualization of the injec-
tions, an unbuffered injectate having a pH of 5.7 was employed.
When 10 parts of the isotope solution was mixed with 1 part of
an artificial proximal solution containing 10 mM/liter bicarbon-
ate (composition in mM/I : 110 Na, 100 Cl, 10 HCO3, 5 K, 4 urea,
1 MgSO4, 1 H2P04, 1 Ca) the pH immediately increased to
that of the bicarbonate containing solution. The microinjections
were made in nephrons in which glomerular filtrate continu-
ously formed and flowed along the tubule. In view of the
continuous mixture of the unbuffered injectate with buffered
tubular fluid, it is unlikely that the pH of the solution once
within the nephron would not have risen to the pH of the
endogenous fluid. The volume of injectate for all experiments
was 24 ni which contained approximately 2000 to 3000 cpm of
[3H1 tobramycin. The amount of tobramycin, per injection was
approximately 66 pg or 0.142 M (molecular wt 468). Sample
volumes were delivered using calibrated constriction micropi-
pettes. The microinjection experiments were initiated after
approximately 1.5 hours of bicarbonate or acid infusion.
Initial errors in pipetting standards indicated the loss of up to
40% of tobramycin due to adherence to glass. At each step in
the sample handling procedure pipettes were rinsed repeatedly
and the radioactivity of the rinse solution measured to account
for isotope loss. Adherence of tobramycin to the 24 nl constric-
tion pipet accounted for 20 to 35% of the loss, adherence to the
glass sample dish accounted for 3 to 5%, and adherence to the
microinjection pipet accounted for the remaining 10 to 15% of
the isotope loss. For this reason, all glassware and micropunc-
ture pipettes used in preparation of the microinjection samples
were silanized with Prosil-28 (specialty chemicals, SCM,
Gainesville, Florida, USA) and dried (100°C) for one hour. This
reduced isotope loss to 5 to 10%. Adherence of isotope was
monitored by rinsing the constriction pipet between samples
and rinsing each micropuncture pipet after the injection had
been made. These counts were subtracted from the isotope
standards to calculate the amount of tobramycin delivered to a
nephron segment. Measured aliquots of the injection solution
were taken up into oil-filled silanized glass micropipettes having
sharpened tips with an external diameter of 8 .tm. A small
amount of colored oil was taken up into the tip to prevent
evaporation of the sample. Six of these pipettes were dispensed
directly into counting vials containing 0.8 ml of distilled water
and were rinsed twice. The coefficient of variation for repetitive
pipetting of standards was less than 1% for ['4C] inulin and 3.2%
for [3H] tobramycin.
Mter the direction of tubular fluid flow was determined by
injecting a small amount of the isotope solution, the injection
was continued over a 15 to 20 second period. Care was taken to
avoid retrograde injection of the isotope solution. Urine was
collected into counting vials during the injection, at 30 second
intervals for the first two minutes following injection and one
minute intervals for the third and fourth minutes. Isotope
excretion was essentially complete within three minutes. After
each injection the pipette was rinsed twice with distilled water
into a counting vial to account for isotope retained on the
interior of the pipet. Data from an injection were accepted only
if the [14C] inulin recovery was at least 95%.
In a separate study, timed collections of proximal tubular
fluid were made in three bicarbonate-infused and three acid-
infused rats. Timed collections of late proximal tubular fluid
were made into sharpened micropipettes with an outer diameter
of 10 pm. Volume of the micropuncture samples was measured
to permit calculations of intratubular flow rate. Timed collec-
tions of urine were made for the measurement of urine flow rate
and pH.
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Bicarbonate
infused
N=7 P
Acid infused
N=lO
Blood pH 7.61 0.030 <0.001 7.17 0.014
Plasma t[C02] m 45.3 2.02 <0.001 15.3 0.87
[HCO3] mM 43.9 2.28 <0.001 14.1 0.72
Urine pH 8.13 0.021 <0.001 5.02 0.057
Urine V ui/minI 20.5 1.85 NS 22.0 3.70
lOOgbody wt
Sample analyses
Radioactivity was measured by liquid scintillation counting
(Beckman LS 3801) in scintillation fluid (Formula 963, New
England Nuclear, Montreal, Canada). Appropriate corrections
were made for background, quenching and spillover of ['4C]
into the [3H] channel. Urine volumes were determined by
weighing, and blood and urine pH was measured in a Radiom-
eter model MPH-72. Plasma total [C02] was measured in a
Corning model 965 CO2 analyzer.
Calculations and statistics
Infusion of hypertonic Na solutions into anesthetized rats
results in an increase in plasma [Na]. In similarly prepared
animals in our laboratory, plasma [Na] in rats infused with the
Na2SO4 solution was 151 1.66mM(N=6)andwas 161 4.22
mM (N = 6) in rats infused with the NaHCO3 solution. The
maximum increase in plasma [Na] measured in an individual
animal was 7%. It is known that as the ionic strength of a
solution increases, PKa and a decrease [17]. However, the
difference in the calculated [HCO3], using PKa and a corrected
for an extreme increase in ionic strength of 25% (corresponding
to a plasma Osm of approximately 376 mOsmlkg H20), PKa' =
6,048, a' = 0.0249, would be quantitatively insignificant (calcu-
lated from data given in [171). For example, if one uses the pH
and total [C02] measured in bicarbonate infused rats (Table 1),
and the corrected PKa' of 6.048 and a' of 0.0249, the calculated
[HCO3} would be 44.1 mM/liter rather than 43.9 mM/liter
(calculated using pk 6.1 a = 0.0301). Since the ionic strength
of plasma was not measured in the present studies a precise
correction to PKa and a could not be applied. Therefore, plasma
bicarbonate concentrations were calculated from the measured
pH and total [C02] using the Henderson-Hasselbach equation
with pk = 6.1 and a for blood = 0.0301.
To allow comparison of data, all [3H} recoveries were divided
by the [14C] inulin recovery for each injection. The percent of
tobramycin reabsorbed was calculated as 100 — the percent of
tobramycin recovery as shown below:
[3H] tobramycin(T)/{'4C] inulin(T) x 100
[3H] tobramycin recovery (%)
where T is the total amount excreted per injection.
% tobramycin reabsorbed = 100 — % tobramycin recovery
To determine whether tobramycin excreted in the urine
followed the same pattern as the unreabsorbed marker-inulin,
the fractions of [3H] tobramycin or ['4C] inulin excreted at each
time interval were calculated as follows: fractional excretion %
[3H] tobramycin [3H] tobramycin tI[3H] tobramycin T, frac-
tional excretion % [14C] inulin = ['4C] inulin t/['4C] inulin T,
where t is the amount excreted at each time interval and T is the
total amount excreted per injection.
Statistical analysis was performed using one-way analysis of
variance and the Newman-Keuls test for multiple comparisons
between experimental groups. Student's I-test for paired data
was used when comparing fractional excretions of [14C] inulin
and [3H] tobramycin and cumulative isotope recoveries for each
microinjection. Student's I-test for unpaired data was used
when comparing systemic and urine parameters between bicar-
bonate infused or acid infused animals. A value of P <0.05 was
considered to be statistically significant. Data are reported as
mean 1 SEM.
Results
Urine and blood acid-base parameters measured in seven
bicarbonate-infused and ten acid-infused rats are summarized in
Table 1. Blood pH and plasma [HCO3] were significantly
elevated in bicarbonate infused animals, and urine pH achieved
Table 1. Systemic acid-base parameters
** **
**
Blood and urine pH and plasma total [C02], and urine flow rate were
measured. Plasma [HCO3] and blood pCO2 (mm Hg) were calculated
(Methods). Values are means Sn; N, number of animals.
**
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Fig. 1. Cumulative [3HJ tobramycin recovery (%, •----•) and f'4C]
inulin (O—O) micro-injected into proximal nephron segments in (A)
acid infused or (B) bicarbonate infused animals at timed intervals. *
0.05, ** P < 0.001.
**
0 30 60 90 120 150 180 210 240
Time, seconds
a maximum of 8.13. The opposite changes were found in blood
pH and plasma [HCO3} in the acid-infused rats and urine pH
decreased to a minimum value of 5.02. However, due to the
osmotic diuresis induced by the bicarbonate and Na2SO4 infu-
sions, urine flow rates were not significantly different between
the two groups. In several animals from each group urine pH
was measured before and after the microinjections were per-
formed. The collections were separated by approximately one
hour. In the bicarbonate infused rats urine ph in the first
collection was 8.06 .057 and was 8.10 .037 (P 0.54) at the
end of the study. Similar results were obtained in acid-infused
rats. Urine pH before the microinjection studies was 5.07
.094 and was 5.00 0.100 (P = 0.613) after the experimental
period.
The time course of the excretion of [3H] tobramycin and ['4C]
inulin following injection into early proximal nephron segments
in acid or bicarbonate infused rats is illustrated in Figure 1 A
and B, respectively. Tobramycin recovery from proximal neph-
ron injections in acid infused rats was clearly less than the
simultaneous recovery of [14C1 inulin in the same nephron (Fig.
1A). In bicarbonate infused rats, the results were qualitatively
similar, however, tobramycin recovery more closely approxi-
mated that of inulin (Fig. lB).
To determine whether tobramycin was reabsorbed by the
proximal nephron or the distal nephron as fluid flowed through
that segment, a series of similar injections were made into distal
convoluted tubules in acid or bicarbonate infused rats. As
illustrated in Figure 2A, cumulative recovery of tobramycin
from distal nephrons in acid infused animals was significantly
less than the simultaneous recovery of inulin. However, virtu-
ally all the [3H] tobramycin injected into distal convoluted
tubules in bicarbonate infused rats was recovered in the urine
with the unreabsorbed-marker [14C] inulin. In bicarbonate
infused animals, [3H} tobramycin recovery was not different
*
*
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Fig. 2. Cumulative [3H] tobramycin recovery
(%, •----•) tobramycin and ['4C1 inulin
______________________________
(• •) microinjected into distal nephronI I I I
segments in (A) acid infused or (B)150 180 210 240 bicarbonate infused animals at timed
intervals. * P < 0.001.
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compared to the ['4C] inulin recovery in each distal nephron
micro-injection. Comparison of data presented in Figures 1 and
2 shows that isotope excretion occurred more rapidly following
injection into distal tubules as expected. In addition, isotope
excretion was virtually complete within two minutes after distal
injections, but required approximately three minutes after prox-
imal injections.
Tobramycin reabsorption following micro-injection into
proximal and distal nephron segments in bicarbonate or acid
infused rats is compared in Figure 3. In acid infused rats, 24.8
1.90% of tobramycin injected into proximal tubules was
reabsorbed compared to only 7.5 1.56% (P < 0.001) when the
animals had been alkalinized. However, when tobramycin was
injected into distal tubules in acid infused animals, significantly
less was reabsorbed compared to proximal tubules in acid
infused animals (5.9 0.75% vs. 24.8 1.90%, P < 0.001). In
bicarbonate infused rats, virtually none of the tobramycin
injected into distal convoluted tubules was reabsorbed (0.43
1.59%). Similar to our results in the proximal nephron, bicar-
bonate loading reduced tobramycin reabsorption in the distal
nephron (Distal Nephron: bicarb, 0.43 1.59% vs. acid, 5.9
75%, P < 0.025).
Fractional excretions of [3H} tobramycin and ['4C] inulin at
timed intervals following injections into proximal nephron
segments in acid or bicarbonate infused animals are depicted in
Figure 4 A and B, respectively. [3H] tobramycin was not
co-excreted with ['4C] inulin in each injection. The excretion of
the aminoglycoside was initially delayed (for example, t = 60
seconds) compared to inulin. Later (t = 180 to 240 seconds),
[3H] tobramycin exceeded the fractional excretion of the la-
beled inulin. A delay in the excretion of tobramycin was
observed, whether a large portion of the tobramycin was
reabsorbed (acid infused rats) or most of the tobramycin
appeared in the urine (bicarbonate infused rats).
In contrast, the analysis of the data from distal nephron
injections showed that [3H] tobramycin was co-excreted with
[14C] inulin in acid or bicarbonate infused animals (Fig. S A and
B). In each nephron, there was no significant difference be-
tween the fraction of [3H] tobramycin and ['4C] inulin excreted
at each time interval.
To determine whether enhanced proximal nephron reabsorp-
tion in acid infused animals was due to a difference in flow rate
in this nephron segment, timed collections of tubular fluid were
made in late proximal tubules in bicarbonate and acid infused
animals. There was no significant difference between late prox-
imal flow rate measured in the two experimental groups (bicar-
bonate infused: 32.8 + 1.88 nI/mm (N = 25) vs. acid infused
30.0 + 2.08 nhlmin (N = 17), NS).
Discussion
The purpose of the present study was to determine if reab-
sorption of tobramycin by proximal and distal nephron seg-
ments in vivo is altered by changes in systemic pH. The results
provide evidence that tobramycin reabsorption occurs primar-
ily in the proximal nephron consistent with the results of a
previous study using gentamicin [9]. However, we have shown
for the first time that reabsorption by the proximal nephron is
substantially reduced by bicarbonate infusion. We also found
there is a small, but significant amount of tobramycin reab-
sorbed by the distal nephron which was prevented by bicarbon-
Proximal Distal
Fig. 3. Tobramycin reabsorption (%) corrected for f'4C] inulin recov-
ery (Methods)following micro-injection intoproximalor distal nephron
segments in bicarbonate infused () or acid infused animals (D).
Probability values between bars indicate the statistical significance of
the difference between the effect of the infusion within a nephron
segment. The difference between proximal vs. distal injection in the
acid infused rats was significant at the level P < 0.001, and was
significant at the level of P < 0.010 in the bicarbonate infused rats.
Number of injections was: proximal-acid infused, N = 20; proximal-
bicarbonate infused, N = 20; distal-acid infused, N = 15; and distal-
bicarbonate infused, N = 11. Statistical analysis performed using
ANOVA and Newman-Keuls test.
ate loading. Although urine flow rates were similar in the two
experimental groups, it was possible that a lower proximal
tubular fluid flow rate in acid infused animals may have con-
tributed to enhanced reabsorption. However, measurement of
late proximal flow rate in single nephrons revealed that flow
rates were similar and could not underlie the difference in
tobramycin reabsorption. It is important to note that the
amount of tobramycin injected into proximal and distal nephron
segments in this study (70 pg) is similar to the filtered load per
single nephron in rats treated to maintain a therapeutic level
between 2 to 10 sgmlml, that is 200 pg/nephron per mm.' Since
our injections were made over 15 to 20 seconds, the amount of
70 pg/injection corresponds to a delivery of 210 pg/nephron per
In theory, tobramycin microinjected into the proximal tubule
may undergo a reversible binding to membrane acidic phospho-
lipids with or without subsequent endocytosis. It may remain in
the cell or exit leading to reabsorption or perhaps re-secretion
by the same or a different nephron segment. It is possible for
membrane bound tobramycin to be released into the lumen of
the tubule, that is, not undergo endocytosis, or to remain bound
to the membrane and undergo endocytosis at some later time.
Results from previous studies using radioautography have
documented significant cellular uptake, five [71 to ten minutes
[81 after introduction of the aminoglycoside. Studies have not
been performed regarding the events occurring for times less
than five minutes. Within the time frame of our microinjection
experiments (4 mm) the examination of the pattern of tobramy-
cm excretion relative to inulin provides some information
concerning the luminal events. Since tobramycin appearance in
l Calculation based on the GFR in the rat of I ml/min/g kidney weight
and 30,000 nephrons/g kidney weight.
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the urine did not precede that of inulin argues against the
existence of tobramycin uptake followed by secretion by a more
distal nephron segment. This is consistent with the earlier
studies of Pastoriza-Munoz et al [9]. Rather, the delayed
excretion of tobramycin relative to inulin following injections
into proximal nephron segments suggests significant interaction
between the aminoglycoside and the luminal membrane of the
proximal tubule even when tobramycin reabsorption was re-
duced by bicarbonate loading. The altered pattern of tobramy-
cm excretion suggests the time constant of binding is relatively
long (on the order of 1 to 2 mm). There was no evidence of
interaction between tobramycin and the luminal membrane of
the distal nephron.
What is the mechanism of tobramycin reabsorption by the
proximal nephron? There is specific, saturable binding of ami-
noglycosides to the brush border membrane of the proximal
tubule [3—5]. Tobramycin, which has five ionizable amino
groups, can displace gentamicin even though it also has five
ionizable amino groups [3, 4]. There is a tendency, however, for
binding affinity to correlate with the number of ionizable amino
groups [3, 5]. Despite the difference in binding affinity, tobra-.
tnycin has been found to be less nephrotoxic than gentamicin
[18, 19]. Binding leads to internalization by the process of
endocytosis [7, 8]. It is of interest that gentamicin has been
shown to competitively inhibit the reabsorption of certain
cationic proteins when both are administered simultaneously
[20]. In addition, Humes, Sastrasinh and Weinberg [4] have
shown that ionized Ca can competitively inhibit gentamicin
brush border membrane interactions. In summary, it appears
that charge interaction underlies the binding of aminoglycosides
and the brush border membrane.
Pastoriza-Munoz et a! [9] were the first to show that [3H]
A
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Fig. 4. Fractional tobramvcin excretion (%, )
compared to ['4CJ inulin ()following micro-
injection into proximal nephron segments in (A)
acid infused or (B) bicarbonate infused animals.
NS See Methods for calculation. Calculations werebased on data from 20 injections in acid infused,
and 20 injections in bicarbonate infused animals.
Bars represent fractions of total counts excreted
180 240 at 30, 60, 90, 120, 180 and 240 second time
intervals.
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gentamicin micro-injected into single nephron segments was
reabsorbed by the proximal tubule. Approximately 30% of the
administered gentamicin was reabsorbed by the proximal neph-
ron in normal rats. In that study 132 pg of gentamicin was used
per injection. They found that the amount of gentamicin reab-
sorbed increased with increasing delivery from approximately
50 to 3000 pg. Even more relevant to the present discussion,
they showed that [3H] gentamicin, which was retained 24
minutes after micro-injection of 2000 pg into a proximal neph-
ron, was not excreted in the urine following the micro-injection
of a great excess of cold gentamicin (4000 pg) into the same
nephron when monitored for 48 minutes. Taken together, the
previous studies suggest that aminoglycoside binding to brush
border membranes leads to removal of the complex by inter-
nalization in proximal cells [5, 7, 8]. The process is similar to
the efficient reabsorption of filtered albumin.
Regarding tobramycin uptake by the distal nephron, it is
important to note that the reabsorption of approximately 6% in
acid-infused rats must be viewed in the context of a pipetting
error of about 3%. However, given the same errors present in
each of our studies, it is clear that all of the tobramycin
micro-injected into distal nephrons in bicarbonate infused ani-
mals, appeared in the urine. Whether the lumina membrane of
the distal nephron has acidic phospholipids similar, although
reduced in number, to the aminoglycoside binding site in the
brush border membrane is not known. However, recent studies
by Matsuda et al [21] show a decrease in distal cell phosphorous
content similar to that observed in proximal tubular cells in rats
with gentamicin nephrotoxicity. These results support the pro-
posal that distal nephron cells may reabsorb aminoglycoside
antibiotics.
How does metabolic alkalosis alter reabsorption of tobramy-
cm? Changes in the pH and [HCO3] of proximal tubule fluid
may alter tobramycin interaction with the brush border. Both
pH and [HCO3] would be increased in proximal tubule fluid in
bicarbonate infused compared to acid infused rats. For exam-
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Fig. 5. Fractional tobramycin excretion (%, )
compared to ['4C] inulin () following micro-
injection into distal nephron segments in (A) acid
infused or (B) bicarbonate infused animals.
Calculations were based on data from 15
injections in acid-infused, and ii injections in
bicarbonate-infused animals. Bars represent
fractions of total counts excreted at 30, 60, 90,
120, 180 and 240 second time intervals.
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pie, pH and [HCO3] of the filtrate would be the same as plasma,
that is, 7.61 and 43.9 m, respectively, in bicarbonate infused
animals. We have previously reported that the pH and [HCO3]
of early distal tubules in similarly prepared bicarbonate infused
rats was 7.66 and 66.4 mrt [15]. In that study, the pH and
[HCO3] were calculated from the measured total CO2 (micro-
calorimetry) using the Henderson-Hasselbaich equation, as-
suming a PCO2 of 60 mm Hg in the distal tubules [22], and a =
0.0309, and pK = 6.10. In acid infused animals, pH and [HCO3]
of filtrate would be 7.17 and 14.1 m, respectively. Early distal
fluid in our previous study was found to have a lower calculated
pH, 6.07 and greatly reduced [HCO3] 1.9 m [15]. Since the pK
of tobramycin is approximately 8.4, the percentage of tobramy-
cm in the charged form would decrease from 90% at pH 7.4, to
50% as the pH approached 8.4. In the acid infused animals there
would be a 10% increase in the fraction of tobramycin in the
charged form as pH progressively declined from 7.4 to 6.4 (that
is, 90% charged to 99% charged). It is possible, however, that
the net charge on the brush border binding site may be altered
by pH and contributes to the reduction in tobramycin binding.
In addition, amino groups may react with CO2 to form the
respective carbamino compounds. This reaction would reduce
the net charge on tobramycin. In the present study, since
systemic and tubular alkalinization are both present, one cannot
determine whether one and/or both are necessary to alter
tobramycin reabsorption.
In summary, the results of the present micro-injection study
show for the first time that tobramycin reabsorption by proxi-
mal and distal segments of outer cortical nephrons is reduced by
bicarbonate loading. Since these experiments were performed
with radioactive tracer, and the tubules are exposed for a brief
period of time, it is difficult to assess the quantitative impor-
tance of the reabsorptive process. However, we recently re-
ported that bicarbonate infusion in animals with tobramycin
plasma levels maintained within the therapeutic range reabsorb
about 6% of the filtered aminoglycoside compared to 20%
reabsorption in acid infused animals [23]. Finally, the results of
our microinjection studies suggest that amelioration of nephro-
toxicity and reduced renal accumulation of gentamicin in rats
receiving NaHCO3, KHCO3 and diamox reported by Aynedjian
et al [141 may be attributed to reduced uptake by the proximal
tubule secondary to alkalinization.
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